IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.
Want to stay updated?Subscribe to our newsletter
Incorporated in 1985, Modern Diagnostic & Research Centre Limited (MDRC) is an Indian diagnostic chain offering diverse services in pathology, radiology, and other related fields.The firm offers credible diagnostic tests, home sample collection services, web-based reporting, and tailored test packages to institutions as well as clients according to their requirements.The organization has 21 centers (18 labs and 3 diagnostic centers) in 8 states with the provision of diagnostic services in ultrasound, CT scan, MRI scan, X-ray, ECG, PFT, and heart and neurological specialties labs.Services:Pathology:MDRC offers a broad range of tests that include high-end molecular, cytogenetics, and focused panels for genetic diseases and neoplasms.Radiology: The facility provides modern imaging services including MRI, CT scans, ultrasound, and digital X-rays, employing cutting-edge technology such as a 3-Tesla MRI machine and a 128-slice CT scanner. Home Sample Collection: The MDRC has a home blood sample collection facility available in a number of cities, allowing patients to save time as they do not need to come to the centre themselves.
Revenue Growth
Kratikal Tech
Atharva Polyplast
Seemax Resources
Sampark India Logistics
Vinit Mobile
Teja Engineering Industries
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
Kratikal Tech SME | 30th Jun 2026 - 2nd Jul 2026 | 39.69 Cr | 1000 Shares | ₹ 128.00 | |
Atharva Polyplast SME | 30th Jun 2026 - 2nd Jul 2026 | 27.00 Cr | 2000 Shares | ₹ 55.00 | |
Seemax Resources SME | 30th Jun 2026 - 2nd Jul 2026 | 19.74 Cr | 1000 Shares | ₹ 134.00 | |
Sampark India Logistics SME | 30th Jun 2026 - 2nd Jul 2026 | 27.22 Cr | 1600 Shares | ₹ 80.00 | |
Vinit Mobile SME | 30th Jun 2026 - 2nd Jul 2026 | 34.13 Cr | 800 Shares | ₹ 150.00 | |
Teja Engineering Industries SME | 30th Jun 2026 - 2nd Jul 2026 | 27.36 Cr | 600 Shares | ₹ 220.00 | |
Knack Packaging Mainboard | 1st Jul 2026 - 3rd Jul 2026 | 439.50 Cr | 88 Shares | ₹ 161.00 |

Open Date
31 Dec 2025
Close Date
02 Jan 2026
Min Investment
₹288000
Lot Size
3200 Shares
Issue Size
₹36.89 Cr
Price Range
₹85 - ₹90
Listing Date
Jan 7, 2026
IPO Doc
RHP PDFCompany Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
The company will utilise ₹20.68 crore for the purchase of medical equipment for diagnostic centres The company will utilise ₹8 crore towards funding working capital requirements The company will utilise ₹1 crore to repay certain outstanding borrowings Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Capital expenditure
55.8%
Working capital
21.6%
Repayment of borrowings
2.7%
General corporate purposes
19.9%
The company will utilise ₹20.68 crore for the purchase of medical equipment for diagnostic centres
The company will utilise ₹8 crore towards funding working capital requirements
The company will utilise ₹1 crore to repay certain outstanding borrowings
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
In Cr.
Revenue: ₹22.67
EBITDA: ₹5.86
Profit: ₹3.00
| Key Performance Indicator | 30-Jun-25 (In Cr.) | 31-Mar-25 (In Cr.) | 31-Mar-24 (In Cr.) | 31-Mar-23 (In Cr.) |
|---|---|---|---|---|
| Revenue | 22.67 | 78.80 | 68.67 | 56.61 |
| EBITDA | 5.86 | 17.96 | 11.05 | -0.99 |
| Expenses | ||||
| Profit After Tax | 3.00 | 8.97 | 5.79 | -5.73 |
| Assets | 77.86 | 64.57 | 49.49 | 36.54 |
| Net Worth | 23.72 | 20.73 | 11.76 | 5.96 |
| Reserves | 12.72 | 9.73 | 10.76 | 4.96 |
| Borrowing | 30.38 | 22.09 | 20.46 | 15.31 |
Mr. Devendra Singh Yadav
Mrs. Deepali Yadav
Mrs. Asha Yadav
Mr. Jitendra Singh
99.99%
72.85%
Modern Diagnostic & Research Centre
Plot No H-64, 1st Floor BLK-H, Bali Nagar City landmark near Khetar Pal Hospital, Ramesh Nagar, West Delhi West Delhi, New Delhi, 110015
MUFG Intime India Pvt.Ltd.